iXCells Biotechnologies社 Expands CRISPR-Cas9 Cell Products and Genome Engineering Services
| この製品に関するご意見・ご照会・お問合せはこちら
|
iXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering Services
Gene Editing Services Deliver Disease Relevant Cell Models to Improve Preclinical Drug Development
May 16, 2023 10:04 AM Eastern Standard Time
SAN DIEGO--(BUSINESS WIRE)--iXCells Biotechnologies (the “Company”), a provider of cell products and drug discovery services to the worldwide academic, biotech and pharmaceutical communities, today announced expansion of its CRISPR-Cas9 product and custom services offering, with special focus on induced pluripotent stem cell (“iPSC”) derived cell models. |
|
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。
